Serum Tumor Markers Panel
Blood tests measuring circulating oncofetal proteins and antigens (CEA, CA-125, PSA, AFP, CA 19-9) for disease tracking and therapy monitoring.
Clinical Overview & Diagnostic Rationale
Tumor markers are biochemical substances released into blood or fluids by cancer cells or host tissue in response to cancer. Monitored sequentially, rising or falling biomarker trends provide valuable objective signals of treatment response or disease progression.
Primary Indications & Clinical Scenarios
Simple venous blood draw. Overnight fasting may be requested if combined with metabolic lipid or liver panels.
Medical Disclaimer: This information is educational and does not replace a consultation with your doctor. Specific diagnostic protocols are individualized following clinical examination at the clinic.
Questions About Your Serum Tumor Markers Panel?
Looking for clear guidance regarding Serum Tumor Markers Panel preparation, scan report terminology, fasting protocols, or diagnostic timelines? Consult Dr. Narendra Rathore's OncoAssist Clinical Guide. Developed for patient FAQs, radiation therapy precautions, chemotherapy guidance, and OPD appointment logistics.
Dr. Narendra Rathore
MBBS, MD (Radiotherapy)Professor and Head of Department, Radiation Oncology
RNT Medical College, Udaipur, Udaipur, Rajasthan
Senior Radiation Oncologist providing clinical evaluations, radiation therapy (3D-CRT/IMRT), chemotherapy planning, and supportive cancer care at RNT Medical College & MB Hospital, Udaipur.
Schedule Your OPD Consultation
All oncology consultations, scan reviews, and treatment planning with Dr. Narendra Rathore are conducted strictly in-person at MB Hospital campus, Udaipur.
- Original Biopsy & Histopathology Reports
- CT / MRI / PET Scan Films & DICOM CDs
- Prior Doctor Prescriptions & Chemotherapy Records
- Patient Photo ID & Scheme Card (RGHS / Chiranjeevi)